As part of its OncView video series, CancerNetwork spoke with Reshma L. Mahtani, DO, Sylvester Comprehensive Cancer Center, about the current role of genomic testing in HR-positive breast cancer and guidance on the use of genomic assays to individualize therapy in the extended adjuvant setting.

 

In the video series, Gadi discussed the following:

·      Extended Adjuvant Therapy for HR+ Breast Cancer

·      NCCN Updates to Genomic Testing in HR+ Breast Cancer

·      Genomic Testing for HR+ Breast Cancer: Best Practices

·      Utilization of The Breast Cancer Index for HR+ Breast Cancer

·      Optimizing Treatment Outcomes in HR+ Breast Cancer

 

To watch more videos in CancerNetwork’s OncView series, visit cancernetwork.com.